Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 22, 2021
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphySamuel Otis-Chapados, Cassandra Ringuette Goulet, Gabriel Dubois, et al.
European Urology|January 18, 2006
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Thierry Lebeau, et al.
Nutrients|March 29, 2023
Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA)Hanane Moussa, Karine Robitaille, Jean-François Pelletier, et al.
Cancers|April 14, 2026
ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate CancerGabriel Boulay, Marwan Khodr, Ann-Charlotte Bergeron, et al.
BMJ Open|February 17, 2025
Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trialIntissar Souli, Julie Lapointe, Jura Kinsley-Marlie, et al.
Urologic Oncology|May 27, 2014
Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract CollaborationVincent Fradet, Julian Mauermann, Wassim Kassouf, et al.
BMJ Open|May 28, 2026
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer riskHanane Moussa, Roxane Tourigny, Karine Robitaille, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 17, 2026
Trajectory timelines and treatment efficacy of <sup>177</sup>Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian centerFrédéric Pouliot, Michele Lodde, Marjorie Besançon, et al.
Communications Medicine|March 23, 2024
A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferationKarine Robitaille, Marie-Hélène Guertin, Afshin Jamshidi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 19, 2020
Psychological morbidity associated with prostate cancer: Rates and predictors of depression in the RADICAL PC studyGagan Fervaha, Jason P Izard, Dean A Tripp, et al.
Pageof 8